Cohance Lifesciences Ltd.

BSE: 543064 | NSE: COHANCE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE03QK01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Cohance Lifesc Cohance Lifesciences Ltd. | BSE 878.10 -7.40 (-0.84%) | NSE 876.40 -10.25 (-1.16%) | Trade | Add

BSE Live

Oct 24, 16:01

878.10 -7.40 (-0.84%)

Volume

AVERAGE VOLUME

5-Day

17,800

10-Day

17,817

30-Day

23,635

6,568

NSE Live

Oct 24, 15:56

876.40 -10.25 (-1.16%)

Volume

AVERAGE VOLUME

5-Day

249,599

10-Day

282,567

30-Day

675,950

175,627

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Cohance Lifesciences (in Rs. Cr.)	Mar 20	Mar 19
Per Share Ratios
Basic EPS (Rs.)	21.22	8.59
Diluted EPS (Rs.)	21.22	8.59
Cash EPS (Rs.)	23.09	9.49
Book Value [ExclRevalReserve]/Share (Rs.)	61.50	46.38
Book Value [InclRevalReserve]/Share (Rs.)	61.50	46.38
Dividend / Share(Rs.)	5.00	1.50
Revenue from Operations/Share (Rs.)	65.51	29.68
PBDIT/Share (Rs.)	31.68	13.53
PBIT/Share (Rs.)	29.81	12.62
PBT/Share (Rs.)	28.09	12.40
Net Profit/Share (Rs.)	21.22	8.59
Profitability Ratios
PBDIT Margin (%)	48.36	45.56
PBIT Margin (%)	45.50	42.52
PBT Margin (%)	42.88	41.78
Net Profit Margin (%)	32.39	28.92
Return on Networth / Equity (%)	34.50	18.51
Return on Capital Employed (%)	41.66	25.68
Return on Assets (%)	24.31	13.95
Total Debt/Equity (X)	0.24	0.14
Asset Turnover Ratio (%)	75.05	48.25
Liquidity Ratios
Current Ratio (X)	1.95	2.47
Quick Ratio (X)	1.08	1.48
Inventory Turnover Ratio (X)	4.77	2.41
Dividend Payout Ratio (NP) (%)	23.56	17.47
Dividend Payout Ratio (CP) (%)	21.65	15.80
Earnings Retention Ratio (%)	76.44	82.53
Cash Earnings Retention Ratio (%)	78.35	84.20
Valuation Ratios
Enterprise Value (Cr.)	2,735.43	0.00
EV/Net Operating Revenue (X)	3.28	0.00
EV/EBITDA (X)	6.78	0.00
MarketCap/Net Operating Revenue (X)	3.08	0.00
Retention Ratios (%)	76.43	82.52
Price/BV (X)	3.28	0.00
Price/Net Operating Revenue	3.08	0.00
Earnings Yield	0.11	0.00